Abstract:
Despite evidence demonstrating the risks of developing diabetes mellitus because of SARSCoV-2, there is, however, insufficient scientific data available to elucidate the relationship between
diabetes mellitus and COVID-19. Research indicates that SARS-CoV-2 infection is associated with
persistent damage to organ systems due to the systemic inflammatory response. Since COVID-19
is known to induce these conditions, further investigation is necessary to fully understand its longterm effects on human health. Consequently, it is essential to consider the effect of the COVID-19
pandemic when predicting the prevalence of diabetes mellitus in the future, especially since the
incidence of diabetes mellitus was already on the rise before the pandemic. Additional research is
required to fully comprehend the impact of SARS-CoV-2 infection on glucose tolerance and insulin
sensitivity. Therefore, this article delves deeper into the current literature and links the perceived
relationship between SARS-CoV-2 and diabetes. In addition, the article highlights the necessity for
further research to fully grasp the mechanisms that SARS-CoV-2 utilises to induce new-onset diabetes.
Where understanding and consensus are reached, therapeutic interventions to prevent the onset of
diabetes could be proposed. Lastly, we propose advocating for the regular screening of diabetes and
pre-diabetes, particularly for the high-risk population with a history of COVID-19 infection.
